The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The need to produce more with less is an ongoing reality in many sectors, including health care. Like developing countries, there are many resource-constrained states in the US where this reality imposes a further burden on the health care system. A state's poverty level results in increased comorbidity rates in rural populations such as cardiovascular disease and obesity. Furthermore, rural residents face significant barriers to health care access, including transfusion medicine services. In addition, rural areas are not staffed with research capabilities or staff routinely engaged in clinical research, making products that require IND and/or IRB-supported processes unfamiliar and less accessible. We will review access challenges to providing transfusion medicine services and products in resource-poor states through this presentation. Using examples and data from the recent COVID-19 pandemic, how the challenges to access TM services and products were overcome will be demonstrated.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
Review transfusion medicine services access challenges in resource-constrained areas.
Describe challenges posed by the COVID -19 pandemic by providing data on utilization of convalescent plasma based on attributes such as rural vs. urban, teaching hospital designation, and hospital size/complexity (availability of tertiary care services).
Demonstrate how challenges to access in transfusion medicine can be overcome through concepts such as allocative efficiency.
Speaker(s):
Tina
Ipe,
MD, MPH,
Division Director of Transfusion Medicine Services,
Department of Pathology and Laboratory Medicine, University of Arkansas for Medical Sciences
Dr. Pampee
P. Young,
MD, PhD,
Chief Medical Officer, Biomedical Services,
American Red Cross Biomedical Services
Disclosures
Pampee Young, MD, PhD:
Medical Advisory Board: Fresenius Kabi; Consultant: Roche, Ortho Diagnositcs
Tina Ipe, MD, MPH:
Consultant, Grant/Research Support: Terumo Blood and Cell Technology; Speaker's Bureau: Alexion Inc.
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
AM21-09: Transfusion Medicine Access in Resource-Constrained Areas Evaluation